内部人交易雷达

美国 · SEC Form 4 · 快照日期: 2026-10-19 · 构建时间: 2026-10-19 · English

← 美国市场 · 覆盖记录

美国 · SEC FORM 4

Warby Parker Inc.

WRBY · NYSE · CIK 0001504776 · Healthcare · Medical Instruments & Supplies

内部人信号

当前没有活跃买入信号

0 qualifying P purchase groups
当前 180 天评分窗口

39 同一窗口内观察到的 Form 4 交易行
14 sales · 25 期权、代扣税、授予、赠与或其他交易行

最近一次合资格买入2024-08-14 · SINGER BRADLEY E · $315.8K

为什么没有活跃信号?

买入活动无
近期买入无
近期卖出中等
买入信号状态未激活
评分构成

活跃窗口内没有合资格买入,因此不计算分数。缺失的输入不会被当作零分或看空信号。

Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算

为什么没有分数?

  • 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
  • 卖出及其他 Form 4 活动继续作为背景显示,不会形成负分。

卖出和其他 Form 4 活动会单独显示,不会形成负面买入信号。没有买入不会被评分为看空。

买方广度、集中度与聚集买入

合资格买入进入 180 天研究窗口后,这些模块才会启用。

内部人活动时间轴

申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。

AprMayJunJulAugSepOct
Blumenthal Neil HarrisCo-Chief Executive Officer
○▼○○○▼○▼○▼○○○▼
Gilboa David AbrahamCo-Chief Executive Officer
○○○▼○▼○○
SINGER BRADLEY EDirector
▼▼○
Raider Jeffrey JacobDirector
○▼▼
Briggs TeresaDirector
○▼
Moon Youngme EDirector
○▼
● 买入▼ 卖出○ 其他

Showing the six most active owners; 2 additional owner(s) remain in Form 4 申报证据.

信号历史

暂无已记录的活跃信号快照

Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2024-08-14 · SINGER BRADLEY E.

近期 Form 4 活动

0买入
35卖出
52其他 Form 4 交易行
42SEC 申报 · 365天
买入0 qualifying P line(s) · 180 days
卖出14 sale line(s) · 仅供背景
其他25 exercise / withholding / award / gift / other lines
10b5-1/计划交易Not assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

市场背景

该股票尚未获取市场背景。每日任务会轮转处理美国股票池。

空头余额

空头余额是券商向 FINRA 申报的外部背景数据,不影响内部人信号。

空头股数
18,197,903
上期报告
17,622,902
日均成交量
4,162,385
回补天数
4.4

FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。

历史股票买入

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting owner类型证券股数平均价格估算金额来源
2024-08-14SINGER BRADLEY E买入 (P)Class A Common Stock25,000USD 12.63USD 315,750SEC 申报 ↗
2024-08-13SINGER BRADLEY E买入 (P)Class A Common Stock50,000USD 13.00USD 650,000SEC 申报 ↗
2022-02-23Durable Capital Partners LP买入 (P)Class A Common Stock404,673USD 27.41USD 11,090,387SEC 申报 ↗
2022-02-18D1 Capital Partners L.P.; Sundheim Daniel S.买入 (P)Class A Common Stock, $0.0001 par value ("Common Stock")240,000USD 27.99USD 6,717,600SEC 申报 ↗
2022-02-17D1 Capital Partners L.P.; Sundheim Daniel S.买入 (P)Common Stock700,000USD 29.21USD 20,447,000SEC 申报 ↗
2022-02-16D1 Capital Partners L.P.; Sundheim Daniel S.买入 (P)Class A Common Stock, $0.0001 par value ("Common Stock")600,000USD 30.50USD 18,300,000SEC 申报 ↗
2022-02-16Durable Capital Partners LP买入 (P)Class A Common Stock315,504USD 30.31USD 9,562,410SEC 申报 ↗
2022-02-15Durable Capital Partners LP买入 (P)Class A Common Stock70,702USD 30.42USD 2,150,607SEC 申报 ↗
2022-02-07Durable Capital Partners LP买入 (P)Class A Common Stock236,615USD 32.86USD 7,774,529SEC 申报 ↗
2022-02-04Durable Capital Partners LP买入 (P)Class A Common Stock115,341USD 32.96USD 3,802,045SEC 申报 ↗
2022-02-03Durable Capital Partners LP买入 (P)Class A Common Stock310,000USD 32.99USD 10,226,800SEC 申报 ↗
2022-02-02Durable Capital Partners LP买入 (P)Class A Common Stock210,552USD 36.03USD 7,586,055SEC 申报 ↗
2022-02-01Durable Capital Partners LP买入 (P)Class A Common Stock19,927USD 36.08USD 718,966SEC 申报 ↗
2022-01-28Durable Capital Partners LP买入 (P)Class A Common Stock141,788USD 35.03USD 4,966,499SEC 申报 ↗
2022-01-27Durable Capital Partners LP买入 (P)Class A Common Stock249,733USD 34.57USD 8,634,498SEC 申报 ↗

Form 4 申报证据

87 transaction lines in the latest 365-day window; 713 in local history.

日期申报人类型证券股数平均价格估算金额来源
2026-10-01Raider Jeffrey Jacob卖出 (S)Class A Common Stock15,000USD 27.70USD 415,500SEC 申报 ↗
2026-10-01Blumenthal Neil Harris卖出 (S)Class A Common Stock100,000USD 27.69USD 2,769,000SEC 申报 ↗
2026-10-01Blumenthal Neil HarrisC (C)Class A Common Stock95,614USD 0.00USD 0SEC 申报 ↗
展开近期 Form 4 证据 (30 grouped rows)
日期申报人类型证券股数平均价格估算金额来源
2026-10-01Raider Jeffrey Jacob卖出 (S)Class A Common Stock15,000USD 27.70USD 415,500SEC 申报 ↗
2026-10-01Blumenthal Neil Harris卖出 (S)Class A Common Stock100,000USD 27.69USD 2,769,000SEC 申报 ↗
2026-10-01Blumenthal Neil HarrisC (C)Class A Common Stock95,614USD 0.00USD 0SEC 申报 ↗
2026-09-02Gilboa David Abraham期权行权/转换 (M)Class A Common Stock20,798USD 0.00USD 0SEC 申报 ↗
2026-09-02Gilboa David Abraham代扣税 (F)Class A Common Stock11,504USD 24.19USD 278,282SEC 申报 ↗
2026-09-02Blumenthal Neil Harris期权行权/转换 (M)Class A Common Stock20,798USD 0.00USD 0SEC 申报 ↗
2026-09-02Blumenthal Neil Harris代扣税 (F)Class A Common Stock11,504USD 24.19USD 278,282SEC 申报 ↗
2026-07-06Gilboa David Abraham卖出 (S)Class A Common Stock54,347USD 29.84USD 1,621,714SEC 申报 ↗
2026-07-06Gilboa David AbrahamC (C)Class A Common Stock54,347USD 0.00USD 0SEC 申报 ↗
2026-07-06Blumenthal Neil Harris卖出 (S)Class A Common Stock9,200USD 29.99USD 275,908SEC 申报 ↗
2026-07-06Blumenthal Neil HarrisC (C)Class A Common Stock9,200USD 0.00USD 0SEC 申报 ↗
2026-07-01Raider Jeffrey Jacob卖出 (S)Class A Common Stock22,500USD 29.72USD 668,700SEC 申报 ↗
2026-07-01Gilboa David Abraham卖出 (S)Class A Common Stock242,221USD 29.69USD 7,191,541SEC 申报 ↗
2026-07-01Gilboa David AbrahamC (C)Class A Common Stock213,746USD 0.00USD 0SEC 申报 ↗
2026-07-01Blumenthal Neil Harris卖出 (S)Class A Common Stock217,667USD 29.61USD 6,445,120SEC 申报 ↗
2026-07-01Blumenthal Neil HarrisC (C)Class A Common Stock189,320USD 0.00USD 0SEC 申报 ↗
2026-06-29Blumenthal Neil Harris卖出 (S)Class A Common Stock36,300USD 30.04USD 1,090,452SEC 申报 ↗
2026-06-29Blumenthal Neil Harris期权行权/转换 (M)Class A Common Stock36,300USD 0.00USD 0SEC 申报 ↗
2026-06-16Briggs Teresa卖出 (S)Class A Common Stock5,000USD 25.94USD 129,683SEC 申报 ↗
2026-06-12Moon Youngme E卖出 (S)Class A Common Stock10,000USD 26.53USD 265,300SEC 申报 ↗
2026-06-08WILLIAMS RONALD A奖励/授予 (A)Class A Common Stock13,006USD 0.00USD 0SEC 申报 ↗
2026-06-08SINGER BRADLEY E奖励/授予 (A)Class A Common Stock9,004USD 0.00USD 0SEC 申报 ↗
2026-06-08Raider Jeffrey Jacob奖励/授予 (A)Class A Common Stock9,004USD 0.00USD 0SEC 申报 ↗
2026-06-08Moon Youngme E奖励/授予 (A)Class A Common Stock9,004USD 0.00USD 0SEC 申报 ↗
2026-06-08Hunt Andrew奖励/授予 (A)Class A Common Stock12,005USD 0.00USD 0SEC 申报 ↗
2026-06-08Briggs Teresa奖励/授予 (A)Class A Common Stock9,004USD 0.00USD 0SEC 申报 ↗
2026-06-02Gilboa David Abraham期权行权/转换 (M)Class A Common Stock20,799USD 0.00USD 0SEC 申报 ↗
2026-06-02Gilboa David Abraham代扣税 (F)Class A Common Stock11,505USD 24.38USD 280,492SEC 申报 ↗
2026-06-02Blumenthal Neil Harris期权行权/转换 (M)Class A Common Stock20,799USD 0.00USD 0SEC 申报 ↗
2026-06-02Blumenthal Neil Harris代扣税 (F)Class A Common Stock11,505USD 24.38USD 280,492SEC 申报 ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

快照与身份

快照日期2026-10-19
排名版本US-v1.2
数据质量PASS ELIGIBLE · —
股票代码WRBY
CIK0001504776
行业Healthcare
细分行业Medical Instruments & Supplies Yahoo Finance
SEC SIC3851 Ophthalmic Goods
交易所NYSE

数据覆盖

本地 Form 4 历史713 transaction lines from 2021-09-27 to 2026-10-01
98 P purchase lines · 356 S sale lines · 259 other lines
SEC 公司申报打开 SEC 申报 ↗

Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.